Xvivo Perfusion AB's market cap is currently ―. The company's EPS TTM is $0.062; its P/E ratio is 344.75; Xvivo Perfusion AB is scheduled to report earnings on April 24, 2023, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	kr 96.83M	kr 94.29M	kr 92.65M	kr 85.86M	kr 54.94M
Gross Profit	kr 69.37M	kr 67.51M	kr 65.22M	kr 63.12M	kr 37.94M
EBIT	kr -4.66M	kr 4.14M	kr 4.62M	kr 17.14M	kr -4.03M
EBITDA	kr -4.66M	kr 4.14M	kr 4.62M	kr 17.14M	kr -4.03M
Net Income Common Stockholders	kr 5.40M	kr 7.53M	kr 4.76M	kr 12.19M	kr -1.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 314.56M	kr 317.88M	kr 339.78M	kr 398.70M	kr 284.52M
Total Assets	kr 1.64B	kr 1.58B	kr 1.52B	kr 1.54B	kr 1.14B
Total Debt	kr 5.54M	kr 6.42M	kr 5.14M	kr 5.72M	kr 4.67M
Net Debt	kr -309.02M	kr -311.46M	kr -334.64M	kr -392.98M	kr -279.85M
Total Liabilities	kr 259.87M	kr 239.00M	kr 224.98M	kr 257.15M	kr 131.84M
Stockholders Equity	kr 1.38B	kr 1.35B	kr 1.30B	kr 1.29B	kr 1.01B
Cash Flow	-
Free Cash Flow	kr 16.97M	kr -1.56M	kr -9.35M	kr -94.64M	kr -8.46M
Operating Cash Flow	kr 16.97M	kr -1.56M	kr -9.35M	kr -562.00K	kr -8.46M
Investing Cash Flow	kr -33.72M	kr -34.48M	kr -52.37M	kr -125.16M	kr -20.21M
Financing Cash Flow	kr -1.62M	kr -556.00K	kr -1.86M	kr 236.90M	kr -1.36M

Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Income Statement >

Xvivo Perfusion AB Debt to Assets

Balance Sheet >

Xvivo Perfusion AB Cash Flow

Cash Flow >

Xvivo Perfusion AB Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing